GlaxoSmithKline | 現金と同等



Cash And Equivalent 変化する 日付
AbbVie USD 5.52B 1.73B 2024-12
Alcon AG USD 1.41B 417M 2025-03
Almirall EUR 377.1M 47.69M 2024-12
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.6B 223.3M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Fresenius EUR 2.39B 105M 2025-03
Fresenius Medical Care EUR 1.07B 109M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
GRIFOLS EUR 752.82M 226.96M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Orion EUR 259.4M 53.8M 2025-03
Pfizer USD 1.43B 387M 2025-03
Philips EUR 1.19B 1.21B 2025-03
Recordati EUR 333.04M 98.02M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Smith & Nephew 568M 266M 2024-06
UCB EUR 1.57B 1.14B 2024-12



GlaxoSmithKline 現金と同等 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.